论文部分内容阅读
18F-脱氧葡萄糖(FDG) PET/CT显像通过反映乳腺癌细胞葡萄糖代谢水平以评价疗效，评价标准主要包括欧洲癌症研究和治疗组织(EORTC)标准和实体瘤疗效PET评价标准(PERCIST)。该文综述并比较了EORTC标准和PERCIST在局部晚期乳腺癌新辅助化疗与复发和(或)转移性乳腺癌系统性治疗临床疗效评价中的应用价值。n “,”Response assessment in breast cancer by n 18F-fluorodeoxyglucose (FDG) PET/CT can measure breast cancer cell glucose metabolic level. The evaluation criteria mainly include the European Organization for Research and Treatment of Cancer (EORTC) criteria and PET response evaluation criteria in solid tumors (PERCIST). This review describes and compares the methods and clinical applications of EORTC criteria and PERCIST in response assessment among patients with locally advanced breast cancer after neoadjuvant chemotherapy and recurrent and (or) metastatic breast cancer after systematic therapy.n